Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Delayed Toronto S.E.
Other stock markets
 02:19:07 2024-06-20 pm EDT 		5-day change 1st Jan Change
0.6 CAD +9.09% Intraday chart for Satellos Bioscience Inc. +3.45% +39.53%
May. 28 Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment MT
May. 28 Satellos Bioscience Inc. Brief: Announcing Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SATELLOS BIOSCIENCE INC.
Bio Therapeutic Drugs
+9.09%+3.45%+39.53%+15.38% - 45.27M
Neutral
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. Comparison Chart